Halozyme Therapeutics
HALO
Hutchmed (China)
HCM
Lantheus
LNTH
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Teradata Corp
TDC
(Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | |
---|---|---|
Operating Cash Flow (Indirect Method) | ||
Cash flow from continuing operating activities | -193.25K | -207.45K |
Net income from continuing operations | --1.66M | ---1.58M |
Operating gains losses | ---1.95M | --1.48M |
Other non cash items | ---2.79K | ---3.6K |
Change In working capital | --94.58K | ---107.27K |
-Change in prepaid assets | --54.39K | ---4.05K |
-Change in payables and accrued expense | --40.19K | ---103.22K |
Cash from discontinued investing activities | ||
Operating cash flow | ---193.25K | ---207.45K |
Investing cash flow | ||
Cash flow from continuing investing activities | ||
Cash from discontinued investing activities | ||
Financing cash flow | ||
Cash flow from continuing financing activities | ||
Cash from discontinued financing activities | ||
Net cash flow | ||
Beginning cash position | --198.93K | --406.38K |
Current changes in cash | ---93.25K | ---207.45K |
End cash Position | --105.68K | --198.93K |
Free cash flow | ---193.25K | ---207.45K |
Currency Unit | USD | USD |